Consideration of adjusted ideal body weight dosing in BG-C9074 (B7-H4–targeting ADC) from pharmacokinetics, efficacy, and safety perspectives.
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Institution: BeOne Medicines (Switzerland)
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7162493723
Cites:
Cited by:
Related to:
